Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sanofi India Ltd (Sanofi India), a subsidiary of Sanofi, is a healthcare company. It focuses on a range of therapeutic areas including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines. The company's product portfolio includes insulin, tablets, vaccines and injection. Sanofi India offers products under the brands Lantus, Allegra, Combiflam, Amaryl, Clexane, Targocid, Frisium, Cardace, Adenocor, Cetapin, Cordarone, Daonil, Myoril, Synvisc, Valparin, Lemtrada, among others. The company has two manufacturing sites in Ankleshwar and Goa. Sanofi India is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
54/A, Sir Mathuradas Vasanji Road, Andheri East, Mumbai, Maharashtra, 400072
Website
www.sanofiindialtd.com
Telephone
91 22 28032000
No of Employees
2,174
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
SANOFI (NSE)
Revenue (2022)
$345.3M
2.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-2.9%
(2022 vs 2021)
Market Cap*
$2.5B
Net Profit Margin (2022)
XYZ
-5.6%
(2022 vs 2021)
* As of and is in US$
Sanofi India Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Drugs | Service: | Lantus |
| Tablets | Export | Allegra |
| Injection | Amaryl | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In March, the company along with Sanofi Healthcare India Private Limited and Cipla Limited entered into a partnership for dispersal and promotion of Sanofi India’s Central Nervous System product range in India. |
| 2024 | Contracts/Agreements | In March, the company entered into a partnership with Emcure Pharmaceuticals Limited for the distribution of SIL’s Cardiovascular products in India. |
| 2023 | Regulatory Approval | In May, the company secured an approval from the board for demerger of consumer health business into its proposed wholly owned subsidiary Sanofi Consumer Healthcare India (SCHIL). |
Competitor Comparison
| Key Parameters | Sanofi India Ltd | Aurobindo Pharma Ltd | Strides Pharma Science Ltd | Hikal Ltd | Astrazeneca Pharma India Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Hyderabad | Bangalore | Mumbai | Bangalore |
| State/Province | Maharashtra | Telangana | Karnataka | Maharashtra | Karnataka |
| No. of Employees | 2,174 | 15,690 | 2,850 | 2,142 | 947 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Aditya Narayan | Chairman | Executive Board | 2016 | - |
| Rachid Ayari | Chief Financial Officer; Director | Executive Board | 2023 | - |
| Rodolfo Hrosz | Managing Director | Senior Management | 2017 | - |
| Radhika Shah | Compliance Officer; Secretary | Senior Management | 2021 | - |
| Himanshu Bakshi | General Manager - Consumer Healthcare business | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer